Platelet-rich plasma sits in an awkward gap in the hair loss world. It is a real medical procedure performed by real clinicians, it has genuine randomized trials behind it, and it is also sold with before-and-after photos and price tags that would make a used car dealer blush. A typical course runs three monthly sessions at $500 to $1,500 each, followed by maintenance sessions every three to six months, indefinitely.

That is a serious financial commitment for a treatment most people have never seen a straight answer about. So here is the straight answer: PRP probably does something measurable for hair density, the effect looks modest rather than transformative, the studies proving it are small and often poorly controlled, and it has never been shown to beat a bottle of minoxidil in a head-to-head trial.

What PRP Actually Is

The procedure is simple in principle. A clinician draws your blood, spins it in a centrifuge to separate out the platelet-rich fraction of the plasma, and injects that concentrate into the thinning areas of your scalp with fine needles. Sessions usually take under an hour. Numbing cream or a nerve block handles most of the discomfort, though people routinely describe the injections as unpleasant rather than painless.

The rationale is that platelets carry growth factors, and delivering a concentrated dose of those growth factors to miniaturizing follicles may push them back toward the anagen, or actively growing, phase. Laboratory work supports the general idea that these growth factors influence the hair cycle. Whether an injection of them into a human scalp produces a result you would notice in the mirror is a separate question, and that is where the trials come in.

It is worth flagging early that PRP is not a standardized product. There is no single formulation. Centrifuge speed, number of spins, platelet concentration, whether the platelets are chemically activated before injection, injection depth, and session spacing all vary between clinics. Two people getting PRP at two different offices may receive meaningfully different treatments under the same name. This lack of standardization is the single biggest problem with interpreting the research, and it is the reason the field still has no agreed protocol after more than a decade.

What the Randomized Trials Found

The two most cited early trials are both half-head designs, meaning each participant received PRP on one side of the scalp and saline placebo on the other. This is a genuinely good design for a treatment like this, because it controls for diet, stress, genetics, and every other confounder by using each patient as their own control.

Gentile and colleagues published the first of these in Stem Cells Translational Medicine in 2015. Twenty-three men with androgenetic alopecia received three PRP sessions at thirty-day intervals, with each scalp divided into frontal, parietal, vertex, and occipital sites. The PRP-treated halves showed increased hair count and density compared with the placebo halves.

Alves and Grimalt followed with a randomized, placebo-controlled, double-blind half-head study in Dermatologic Surgery in 2016. Twenty-five patients received three PRP treatments a month apart. Six months after the first treatment, the PRP side showed meaningful changes from baseline in the proportion of anagen hairs, telogen hairs, overall hair density, and terminal hair density. The authors concluded that PRP had a positive effect and could reasonably be considered an adjuvant therapy, which is a deliberately modest word choice.

Notice the sample sizes. Twenty-three men. Twenty-five patients. These are small studies, and small studies are where dramatic effect sizes go to be overestimated.

What the Meta-Analyses Say

Pooling the trials gives a clearer picture. Zhang and colleagues published a systematic review and meta-analysis in the Journal of Cutaneous Medicine and Surgery in 2023, covering nine randomized controlled trials and 238 patients total. Their finding is the most useful single summary of this literature.

PRP increased hair density at three and six months with a statistically significant difference compared with placebo. But hair count and hair diameter, while improved compared with each patient’s own baseline, showed no statistically significant difference compared with placebo. No serious adverse reactions turned up across the included trials.

That split matters. Density improving while count and diameter fail to separate from placebo suggests the effect is real but small, and that some of what patients and clinicians perceive as improvement is the ordinary noise of hair measurement plus the powerful expectation effects that come with paying a thousand dollars and sitting through a procedure.

PRP Versus Minoxidil, Head to Head

This is the comparison that should drive the decision, and it has actually been tested.

Balasundaram, Kumari, and Ramassamy ran a randomized open-label trial published in the Journal of Dermatological Treatment in 2023. Sixty-four men with moderate androgenetic alopecia were randomized to either 5% topical minoxidil for six months or PRP injections monthly for three months.

At week 24, 56% of the minoxidil group responded, compared with 38% of the PRP group. That difference did not reach statistical significance, so the honest reading is that the two treatments performed comparably rather than that minoxidil won outright. But the secondary outcomes are hard to ignore. Adverse events occurred in 53% of the PRP group versus 37% of the minoxidil group, and patient satisfaction was better with minoxidil.

So the expensive, needle-based, clinic-dependent treatment did not outperform a topical you can buy without a prescription, and it caused more side effects. That is not an argument that PRP does nothing. It is an argument about sequencing and value.

Where PRP Might Genuinely Add Something

The more interesting question is not PRP instead of minoxidil, but PRP on top of minoxidil.

A systematic review and meta-analysis published in PLOS One in 2024 examined exactly this, pooling five randomized controlled trials comparing PRP plus topical minoxidil against minoxidil alone. Hair density favored the combination at one month, three months, and five to six months of follow-up. Adverse event rates were comparable between the two groups.

That sounds encouraging, and it is the strongest case for PRP. But the same paper is unusually blunt about its own limitations. Three of the five included trials were judged to be at high risk of bias, and one more raised concerns. The certainty of the evidence on GRADE assessment, the standard framework for rating how much confidence a body of evidence deserves, came out as low to very low. The authors’ own phrasing is that very low quality evidence suggests adding PRP to minoxidil may improve outcomes.

Low to very low certainty is not a technicality. It means future well-designed trials could plausibly overturn the finding entirely.

How to Think About the Cost

Run the arithmetic before booking anything. Three initial sessions plus maintenance every four months lands most people somewhere between $2,500 and $6,000 in the first year, and PRP is not a one-time purchase. Like every other treatment for androgenetic alopecia, the underlying condition continues if you stop, so the maintenance schedule is permanent.

For comparison, a year of generic minoxidil runs roughly $50 to $150. Microneedling with a derma stamp, which has its own randomized evidence as a minoxidil add-on and shares the general premise of controlled scalp injury stimulating a wound-healing response, costs under $20 for a tool that lasts months.

This is not an argument that cheap always beats expensive. It is an argument about order of operations. Spending several thousand dollars a year on a treatment with low-certainty evidence, while skipping the treatments with the strongest evidence and the lowest cost, is a common and expensive mistake.

A Reasonable Sequence

If you are considering PRP, the sensible order looks something like this.

First, establish a proven baseline and give it a fair trial. Topical minoxidil has the deepest evidence base of anything available without a prescription, and it needs a genuine six to twelve months before you can judge it. Anyone evaluating PRP without having done this first is measuring PRP against nothing.

Second, talk to a clinician about DHT-blocking medication. Finasteride and dutasteride address the hormonal driver of androgenetic alopecia rather than working around it, and no amount of PRP substitutes for that mechanism. These are prescription medications with real side effect profiles that require a doctor’s assessment, not a decision to make from a blog post.

Third, consider low-cost add-ons like microneedling and ketoconazole shampoo, which stack cheaply onto an existing routine.

Only then does PRP make sense as a consideration, and specifically as an add-on to a working routine rather than a replacement for one. That framing matches the evidence: the strongest data for PRP is the combination data, not the monotherapy data.

Questions Worth Asking a Clinic

Because PRP is unstandardized, the specifics of who is treating you matter more than usual. Reasonable things to ask before paying:

  • What is the preparation protocol, including centrifuge system, number of spins, and whether the platelets are activated?
  • What platelet concentration does the system produce relative to whole blood?
  • How many sessions are in the initial course, and what is the proposed maintenance schedule and annual cost?
  • What objective tracking is used, such as standardized photography or trichoscopy with hair counts, rather than impressions?
  • What happens if there is no measurable response at six months?

A clinic that cannot answer the first two questions is not necessarily doing anything wrong, but it does tell you they are not tracking the variables the research says matter most.

The Bottom Line

PRP is not snake oil. It has randomized, placebo-controlled evidence, it appears to increase hair density modestly, and across the pooled trials it has a reassuring safety record with no serious adverse reactions reported.

It is also oversold. The effect on hair count and diameter has not separated from placebo in pooled analysis. It did not beat topical minoxidil head to head, and caused more side effects when tested against it. The best evidence for it, as a minoxidil add-on, rests on a body of research the reviewers themselves rate as low to very low certainty. And it costs one to two orders of magnitude more per year than the treatments it is supposed to supplement.

If you have money to spend, a working baseline routine already in place, and realistic expectations calibrated to modest density gains rather than restoration, PRP is a defensible thing to try. If you are looking at it as a first move, or as a way to avoid medication, the evidence does not support that.

As always, prescription treatments and in-office procedures require a doctor. A dermatologist can confirm that what you are treating is actually androgenetic alopecia, because several other causes of hair loss look similar in the mirror and respond to completely different treatment. That diagnosis is worth more than any product decision on this page.